SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-461303
Filing Date
2012-11-09
Accepted
2012-11-08 21:55:20
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d409475d10q.htm 10-Q 684814
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) d409475dex311.htm EX-31.1 9100
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) d409475dex312.htm EX-31.2 9175
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d409475dex321.htm EX-32.1 4990
  Complete submission text file 0001193125-12-461303.txt   4833678

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arna-20120930.xml EX-101.INS 574800
6 XBRL TAXONOMY EXTENSION SCHEMA arna-20120930.xsd EX-101.SCH 50097
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20120930_cal.xml EX-101.CAL 62711
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20120930_def.xml EX-101.DEF 232537
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20120930_lab.xml EX-101.LAB 365496
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20120930_pre.xml EX-101.PRE 282424
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 121191536
SIC: 2834 Pharmaceutical Preparations